LGM
Logos Global Management Portfolio holdings
AUM
$749M
This Quarter Return
-5.77%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$1.17B
AUM Growth
+$1.17B
(+14%)
Cap. Flow
+$299M
Cap. Flow
% of AUM
25.68%
Top 10 Holdings %
Top 10 Hldgs %
51.12%
Holding
71
New
18
Increased
15
Reduced
14
Closed
14
Top Buys
| 1 |
VERV
Verve Therapeutics
VERV
|
$45.7M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$38M |
| 3 |
LENZ
LENZ Therapeutics
LENZ
|
$32.9M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$29.3M |
| 5 |
Century Therapeutics
IPSC
|
$29M |
Top Sells
| 1 |
Dyne Therapeutics
DYN
|
$24.2M |
| 2 |
Repare Therapeutics
RPTX
|
$17.8M |
| 3 |
BioXcel Therapeutics
BTAI
|
$17.3M |
| 4 |
Kymera Therapeutics
KYMR
|
$10.1M |
| 5 |
VINC
Vincerx Pharma, Inc. Common Stock
VINC
|
$9.26M |
Sector Composition
| 1 | Healthcare | 99.71% |
| 2 | Financials | 0.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Janux Therapeutics
JANX
$1.37B
| $13.7M | 1.15% |
+547,122
| New | +$13.7M |
|
27
Kezar Life Sciences
KZR
$28.9M
| $12.5M | 1.05% |
2,300,000
+1,500,000
| +188% | +$8.15M |
|
|
RAIN
28
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $12.1M | 1.02% |
+780,331
| New | +$12.1M |
|
29
Aclaris Therapeutics
ACRS
$209M
| $11.9M | 1% |
+675,000
| New | +$11.9M |
|
30
Cogent Biosciences
COGT
$1.69B
| $11.5M | 0.97% |
1,420,500
| – | – |
|
31
Prelude Therapeutics
PRLD
$68.5M
| $11.5M | 0.96% |
+400,000
| New | +$11.5M |
|
32
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $11.1M | 0.94% |
800,000
+400,000
| +100% | +$5.57M |
|
|
HARP
33
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $11.1M | 0.93% |
800,000
+500,000
| +167% | +$6.94M |
|
34
Eledon Pharmaceuticals
ELDN
$155M
| $10.6M | 0.89% |
1,339,793
+1,115,722
| +498% | +$8.83M |
|
|
LABP
35
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
| $10.4M | 0.87% |
899,106
+165,106
| +22% | +$1.91M |
|
|
36
Repare Therapeutics
RPTX
$71.7M
| $10.3M | 0.86% |
330,000
-570,000
| -63% | -$17.8M |
|
37
RAPT Therapeutics
RAPT
$188M
| $8.58M | 0.72% |
+270,000
| New | +$8.58M |
|
38
Tourmaline Bio
TRML
$601M
| $7.46M | 0.63% |
+507,923
| New | +$7.46M |
|
39
Cullinan Oncology
CGEM
$445M
| $7.43M | 0.62% |
288,458
-125,000
| -30% | -$3.22M |
|
40
PMV Pharmaceuticals
PMVP
$74.2M
| $7.06M | 0.59% |
206,564
+6,564
| +3% | +$224K |
|
41
Monte Rosa Therapeutics
GLUE
$296M
| $6.81M | 0.57% |
+300,000
| New | +$6.81M |
|
42
Astria Therapeutics
ATXS
$349M
| $6.73M | 0.57% |
+3,190,000
| New | +$6.73M |
|
|
ASLN
43
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $6.6M | 0.55% |
2,000,000
-300,000
| -13% | -$990K |
|
44
Aligos Therapeutics
ALGS
$73.3M
| $4.34M | 0.36% |
212,785
-263,762
| -55% | -$5.38M |
|
45
C4 Therapeutics
CCCC
$185M
| $4.27M | 0.36% |
112,928
| – | – |
|
|
IMA
46
ImageneBio, Inc. Common Stock
IMA
$150M
| $4.21M | 0.35% |
299,853
-120,000
| -29% | -$1.68M |
|
47
Annexon
ANNX
$226M
| $3.59M | 0.3% |
159,622
| – | – |
|
48
Tango Therapeutics
TNGX
$747M
| $2.28M | 0.19% |
200,000
| – | – |
|
|
ARYD
49
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $2.14M | 0.18% |
200,000
| – | – |
|
50
Passage Bio
PASG
$22.7M
| $1.66M | 0.14% |
125,010
| – | – |
|